|
Sign In to gain access to subscriptions and/or personal tools.
|
Antiplatelet Therapy for Vascular Interventions
Anthony J. Comerota, MD, FACS, FACC*
and
Subhash Thakur, MD
Jobst Vascular Center, The Toledo Hospital
* To whom correspondence should be addressed. E-mail: marilyn.gravett{at}promedica.org.
 |
Abstract |
|---|
The role of platelets and the importance of platelet inhibition are well established in patients with vascular disease. When physicians perform revascularization procedures in these patients, who typically have the most advanced atherosclerotic disease, they should be aware of both the generic benefits of platelet inhibition on patients’ long-term health as well as the specific benefits relative to operative or endovascular revascularization. Platelet inhibition has not been well studied in the aortoiliac system, renal vascular bed, or the mesenteric arterial bed. Peripheral vascular beds that have been studied are predominantly the carotid circulation and the infrainguinal vasculature. This article reviews the basic mechanisms of platelet inhibition and suggests antiplatelet strategies for vascular interventions, including carotid endarterectomy, carotid angioplasty and stenting, infrainguinal bypass, and peripheral angioplasty and stenting.
First published on April 2, 2008, doi:10.1177/1531003507313220
Perspectives in Vascular Surgery and Endovascular Therapy 2008;20:28.
A more recent version of this article appeared on March 1, 2008
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
|
|
